Pendal Group LTD Charles River Laboratories International, Inc. Transaction History

Pendal Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$294.17 - $371.65 $323,587 - $408,815	-1,100 Closed	0 $0
Q1 2021 May 24, 2021	BUY	$249.67 - $299.48 $274,637 - $329,428	1,100 New	1,100 $319,000
Q1 2021 May 03, 2021	SELL	$249.67 - $299.48 $274,637 - $329,428	-1,100 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$222.0 - $252.62 $244,200 - $277,882	1,100 New	1,100 $275,000

708

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.67B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.